Real-time nucleic acid sequence-based amplification to predict the clinical outcome of invasive aspergillosis

Journal of Korean Medical Science

Volumn 27, Issue 1, 2012, Pages 10-15

  Kim, Si Hyun ^a   Park, Chulmin ^a   Kwon, Eun Young ^a   Shin, Na Young ^a   Kwon, Jae Cheol ^a   Park, Sun Hee ^a   Choi, Su Mi ^a   Lee, Dong Gun ^a   Choi, Jung Hyun ^a   Yoo, Jin Hong ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Aspergillosis; Nucleic acid sequence based amplification; Treatment outcome

Indexed keywords

ANTIFUNGAL AGENT; RNA 18S;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LUNG; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SPUTUM; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; BASE SEQUENCE; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, RIBOSOMAL, 18S; SPUTUM; SURVIVAL RATE;

EID: 84863182024     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2012.27.1.10     Document Type: Article

References (30)

1. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-17.
2. Yoo JH, Lee DG, Choi SM, Choi JH, Park YH, Kim YJ, Kim HJ, Lee S, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. Bone Marrow Transplant 2004; 34: 497-504.
3. Slobbe L, Polinder S, Doorduijn JK, Lugtenburg PJ, El Barzouhi A, Steyerberg EW, Rijnders BJ. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study. Clin Infect Dis 2008; 47: 1507-12.
4. Maschmeyer G, Haas A, Cornely OA. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 2007; 67: 1567-601.
5. Wheat LJ, Walsh TJ. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur J Clin Microbiol Infect Dis 2008; 27: 245-51.
6. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40: 1762-9.
7. Caillot D, Couaillier JF, Bernard A, Casasnovas O, Denning DW, Mannone L, Lopez J, Couillault G, Piard F, Vagner O, Guy H. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253-9.
8. Brodoefel H, Vogel M, Hebart H, Einsele H, Vonthein R, Claussen C, Horger M. Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome. AJR Am J Roentgenol 2006; 187: 404-13.
9. Perlin DS, Zhao Y. Molecular diagnostic platforms for detecting Aspergillus. Med Mycol 2009; 47: S223-32.
10. Yoo JH, Choi JH, Choi SM, Lee DG, Shin WS, Min WS, Kim CC. Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases. Clin Infect Dis 2005; 40: 392-8.
11. Yoo JH, Choi SM, Lee DG, Park SH, Choi JH, Kwon EY, Shin WS. Comparison of the real-time nucleic acid sequence-based amplification (RTi-NASBA) with conventional NASBA, and galactomannan assay for the diagnosis of invasive aspergillosis. J Korean Med Sci 2007; 22: 672-6.
12. Yoo JH, Choi SM, Choi JH, Kwon EY, Park C, Shin WS. Construction of internal control for the quantitative assay of Aspergillus fumigatus using real-time nucleic acid sequence-based amplification. Diagn Microbiol Infect Dis 2008; 60: 121-4.
13. Park C, Kwon EY, Shin NY, Choi SM, Kim SH, Park SH, Lee DG, Choi JH, Yoo JH. Evaluation of nucleic acid sequence based amplification using fluorescence resonance energy transfer (FRET-NASBA) in quantitative detection of Aspergillus 18S rRNA. Med Mycol 2011; 49: 73-9.
14. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
15. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-51.
16. Patterson SS, Casper ET, Garcia-Rubio L, Smith MC, Paul JH 3rd. Increased precision of microbial RNA quantification using NASBA with an internal control. J Microbiol Methods 2005; 60: 343-52.
17. Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BE. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis 2008; 47: 674-83.
18. Chmura Kraemer H, Periyakoil VS, Noda A. Kappa coefficients in medical research. Stat Med 2002; 21: 2109-29.
19. Segal BH. Aspergillosis. N Engl J Med 2009; 360: 1870-84.
20. Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12: 310-50.
21. Wiederhold NP, Najvar LK, Vallor AC, Kirkpatrick WR, Bocanegra R, Molina D, Olivo M, Graybill JR, Patterson TF. Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 2008; 52: 1176-8.
22. Vallor AC, Kirkpatrick WR, Najvar LK, Bocanegra R, Kinney MC, Fothergill AW, Herrera ML, Wickes BL, Graybill JR, Patterson TF. Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob Agents Chemother 2008; 52: 2593-8.
23. Park SH, Choi SM, Lee DG, Choi JH, Kim SH, Kwon JC, Yoo JH, Kim HJ, Lee S, Eom KS, Min WS. Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients. Mycoses 2011; 54: 523-30.
24. Yoo JH, Lee DG, Choi SM, Shin WS. Evaluation of nucleic acid sequencebased amplification (NASBA) for diagnosis and monitoring of invasive aspergillosis: a preliminary report. Infect Chemother 2003; 35: 99-106.
25. Maertens J, Buve K, Theunissen K, Meersseman W, Verbeken E, Verhoef G, Van Eldere J, Lagrou K. Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 2009; 115: 355-62.
26. Koo S, Bryar JM, Baden LR, Marty FM. Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol 2010; 48: 1255-60.
27. Woods G, Miceli MH, Grazziutti ML, Zhao W, Barlogie B, Anaissie E. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. Cancer 2007; 110: 830-4.
28. Hummel M, Spiess B, Cornely OA, Dittmer M, Mörz H, Buchheidt D. Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial. Eur J Haematol 2010; 85: 164-9.
29. Bretagne S. Primary diagnostic approaches of invasive aspergillosis: molecular testing. Med Mycol 2011; 49: S48-53.
30. White PL, Bretagne S, Klingspor L, Melchers WJ, McCulloch E, Schulz B, Finnstrom N, Mengoli C, Barnes RA, Donnelly JP, Loeffler J; European Aspergillus PCR Initiative. Aspergillus PCR: one step closer to standardization. J Clin Microbiol 2010; 48: 1231-40.